HUTCHMED (China) (HMDCF) Operating Margin (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Operating Margin came in at 278.72% in Q1 2021, up 443.0% year-over-year from 51.33% in Q1 2020, and up 183.76% quarter-over-quarter from 98.23% in Q2 2020.
Analysis
HUTCHMED (China) (HMDCF) Operating Margin (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Operating Margin for 4 consecutive years, with 278.72% the latest figure, recorded in Q1 2021.
- On a quarterly basis, Operating Margin rose 443.0% year-over-year to 278.72% in Q1 2021; TTM through Mar 2021 was 159.12%, a 17919.0% increase from a year earlier, with the FY2025 full-year figure at 7.14%, down 20.0% from the prior year.
- Operating Margin was 278.72% for Q1 2021 at HUTCHMED (China), up from 98.23% in the prior quarter.
- Over five years, Operating Margin peaked at 278.72% in Q1 2021 and troughed at 303.37% in Q4 2018.
- A 4-year average of 17.39% and a median of 25.14% in 2018 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin plunged 37387 bps in 2019 and soared 31422 bps in 2020, its largest moves.
- Over 4 years, Operating Margin stood at 303.37% in 2018, then soared by 76 bps to 72.05% in 2019, then surged by 236 bps to 98.23% in 2020, then jumped by 184 bps to 278.72% in 2021.
- The last three Operating Margin figures came in at 278.72% (Q1 2021), 98.23% (Q2 2020), and 274.29% (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.13 Bn | 197.14 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 132.23 Bn | 124.38 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 82.91 Bn | 74.92 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 55.02 Bn | 49.89 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 30.18 Bn | 30.18 Bn | 1.16 Mn | -25,380.93% |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 278.72% |
| Jun 30, 2020 | 98.23% |
| Mar 31, 2020 | 274.29% |
| Dec 31, 2019 | -72.05% |
| Sep 30, 2019 | -72.83% |
| Jun 30, 2019 | -216.00% |
| Mar 31, 2019 | 69.10% |
| Dec 31, 2018 | -303.37% |
| Sep 30, 2018 | 25.14% |
| Jun 30, 2018 | 157.88% |
| Mar 31, 2018 | -47.81% |